Lamotrigine in motor and mood symptoms of Huntington's disease

World Journal of Biological Psychiatry

Volumn 9, Issue 2, 2008, Pages 147-149

  Shen, Yu Chih ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Choreoathetoidic movements; Glutamate; Huntington's disease; Lamotrigine; Mood swing

Indexed keywords

CLONAZEPAM; LAMOTRIGINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CHOREOATHETOSIS; COGNITION; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; EVENING DOSAGE; EXPERIENCE; FEMALE; HOSPITAL ADMISSION; HUMAN; HUNTINGTON CHOREA; INSOMNIA; MOOD DISORDER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; RECURRENT DISEASE; SUICIDE ATTEMPT; SYMPTOM;

ANTIMANIC AGENTS; ATROPHY; CAUDATE NUCLEUS; CEREBRAL CORTEX; CHOREA; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MOOD DISORDERS; TRIAZINES;

EID: 42449137917     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701332520     Document Type: Article

References (15)

1. Bezprozvanny, I. and Hayden, MR (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun, 322, pp. 1310-1317.
2. Bonelli, RM and Wenning, GK (2006) Pharmacological management of Huntington's disease: An evidence-based review. Curr Pharm Des, 12, pp. 2701-2720.
3. Bowden, CL, Calabrese, JR and Sachs, G. (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry, 60, pp. 392-400.
4. Bowden, CL, Asnis, GM, Ginsberg, LD, Bentley, B., Leadbetter, R. and White, R. (2004) Safety and tolerability of lamotrigine for bipolar disorder. Drug Saf, 27, pp. 173-184.
5. Calabrese, JR, Bowden, CL and Sachs, G. (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry, 64, pp. 1013-1024.
6. Craufurd, D., Thompson, JC and Snowden, JS (2001) Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol, 14, pp. 219-226.
7. Group THsDCR (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 72, pp. 971-983.
8. Ketter, TA, Manji, HK and Post, RM (2003) Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol, 23, pp. 484-495.
9. Kremer, B., Clark, CM and Almqvist, EW (1999) Influence of lamotrigine on progression of early Huntington disease: A randomized clinical trial. Neurology, 53, pp. 1000-1011.
10. Naarding, P., Kremer, HP and Zitman, FG (2001) Huntington's disease: A review of the literature on prevalence and treatment of neuropsychiatric phenomena. Eur Psychiatry, 16, pp. 439-445.
11. Rosenblatt, A. and Leroi, I. (2000) Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics, 41, pp. 24-30.
12. Rico, A Royuela, Gil-Verona, JA and Fernandez, JA Macias (2003) A case of obsessive symptoms in Huntington's disease. Actas Esp Psiquiatr, 31, pp. 367-370.
13. Vonsattel, JP and DiFiglia, M. (1998) Huntington disease. J Neuropathol Exp Neurol, 57, pp. 369-384.
14. Vonsattel, JP, Myers, RH, Stevens, TJ, Ferrante, RJ, Bird, ED and Richardson Jr, EP (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol, 44, pp. 559-577.
15. Young, AB, Shoulson, I. and Penney, JB (1986) Huntington's disease in Venezuela: Neurologic features and functional decline. Neurology, 36, pp. 244-249.